In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Published Date: 16 Feb 2024

With crenolanib, the complete response rate was 86%, and the median event-free survival was almost four years.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

Implant-based reconstruction linked to increased risk of breast lymphomas

3.

Millions of men could benefit from faster scan to diagnose prostate cancer

4.

Use of social media during pregnancy may increase depression.

5.

Video: Liver transplant for patients with advanced colorectal cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot